BOT 1.41% 35.0¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-380

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,120 Posts.
    lightbulb Created with Sketch. 577
    in nature things mutate and in the medical space confidence intervals of 99.99% are too low. synthetic drugs are preferred for purity 99.9999999 and scalability of production.

    a lot of the drugs you take are synthetic versions

    most drugs that are approved are also single compounds. I guess it's 1 = 1 in the science world that you are trying to find out. as soon as you have 1+2= 3 into the mix I guess the complexity multiplies. there is a recent podcast on compounding med products.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.005(1.41%)
Mkt cap ! $640.6M
Open High Low Value Volume
35.5¢ 36.0¢ 34.5¢ $1.196M 3.408M

Buyers (Bids)

No. Vol. Price($)
29 531939 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 340926 12
View Market Depth
Last trade - 13.33pm 17/10/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.